0 followers
They aspire to control the immune system. By the time a patient is sitting in front of an oncologist, cancer has evaded their immune system. Chimeric antigen receptor T-cells (CARs) are reprogrammed immune cells, hot-wired to circumvent immune-evasion. Clinical trials for CARs against liquid tumor c... Read more
Vlad Hogenhuis, MD, MBA
Merck
195 followers
BioAge
3 followers
Abbott
264 followers
Thermo Fisher Scientific
141 followers
Regeneron
88 followers
Vertex Pharmaceuticals
50 followers
Verily Life Sciences
36 followers
Alexion Pharmaceuticals
32 followers
ADARx Pharmaceuticals
2 followers
Pfizer
441 followers
PerkinElmer
8 followers
Discover companies